<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteMolecular Robotics &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 19 Nov 2026 18:05:57 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/focus-area/molecular-robotics/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>FINDing new drug leads faster with DNA nanotechnology</title>
				<link>https://wyss.harvard.edu/news/finding-new-drug-leads-faster-with-dna-nanotechnology/</link>
        <pubDate>Thu, 05 Nov 2026 18:45:51 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[DNA Nanoswitches]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Wesley Wong]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=46551</guid>
                            <description>DNA nanoswitch platform rapidly searches large libraries for molecules that change how different proteins interact, introducing unprecedented functionality and efficiency into drug screening</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Researchers at the Wyss Institute at Harvard University, Boston Children&rsquo;s Hospital, and Harvard Medical School (HMS) have developed FIND, a drug discovery platform that searches large libraries for molecules that modulate binding interactions between two proteins. FIND uses DNA nanoswitches to select drug candidates based on their effects on these protein&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/finding-new-drug-leads-faster-with-dna-nanotechnology/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/finding-new-drug-leads-faster-with-dna-nanotechnology/</link>
          <title>Wyss Institute Faculty member Wesley Wong and the two co-first authors Clinton Hanson and Mark Lipstein developed FIND as a DNA nanotechnology-powered drug discovery platform that rapidly identifies drug molecules based on their ability to modulate disease-relevant protein-protein interactions. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/11/03100421/DNA-Nanoswitch-Team-0359_Revised-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1efbe51578f7935fe2e2ef6bbf7e6813"/></url>
				</image>
        			</item>

		
			<item>
				<title>Building big with DNA gets a software upgrade</title>
				<link>https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/</link>
        <pubDate>Wed, 16 Sep 2026 13:55:09 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=46184</guid>
                            <description>New computational framework for crisscross fabrication of micrometer-scale DNA megastructures with nanoscale precision broadens accessibility to this powerful nanotechnology</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; 44 years ago, Nadrian Seeman published his groundbreaking ideas on using DNA as a structural material, expanding DNA&rsquo;s significance way beyond that as a carrier of genetic information. Since then, the steadily growing field of DNA nanotechnology has seen numerous innovations. One of them was the DNA origami technique, which enables researchers to fold a single&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/</link>
          <title>The team used their easily accessible computational framework, #-CAD, to design and fabricate a series of complex Crisscross DNA megastructures from start to finish. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/09/14094955/Crisscross_listing-image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=84351ede948e19b68f2dc6ce79cd8d84"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2026-2027 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
        <pubDate>Mon, 06 Jul 2026 14:00:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Endometriosis]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45679</guid>
                            <description>From diagnostics and therapeutics to sustaining life on our planet, 23 Wyss teams are moving promising ideas closer to real-world impact</description>
                                        <content:encoded><![CDATA[<p>Each year, the Wyss Institute&rsquo;s Validation Project program identifies technologies that are ready to move beyond discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de&#x2d;risk high&#x2d;impact innovations&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
          <title>One Sarah's favorite things about the Wyss is being surrounded by others who are also trying to translate their technologies into companies. Here, she poses with a few of her entrepreneurial friends and colleagues. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/17153558/Sarah-and-Elizabeth-Candid-Neutral-07507-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bbbb793b3dc71fe4c18d05511384ed06"/></url>
				</image>
        			</item>

		
			<item>
				<title>Sarah Sandler on sailing towards a new solution for drug discovery</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/</link>
        <pubDate>Tue, 23 Jun 2026 15:27:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45589</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. In sailing and in science, it&rsquo;s important to communicate and stay calm in stressful situations, which is something postdoctoral fellow Sarah Sandler knows well. As a competitive sailor&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-sarah-sandler-on-sailing-towards-a-new-solution-for-drug-discovery/</link>
          <title>Sarah Sandler, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/17131500/WoW-2026-Sarah-Sandler-Neutral-07439-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=0b67e28ea67f1225b578d0de47f600eb"/></url>
				</image>
        			</item>

		
			<item>
				<title>Building protection against infectious diseases with nanostructured vaccines</title>
				<link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
        <pubDate>Wed, 11 Mar 2026 12:56:44 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45012</guid>
                            <description>Wyss Institute’s DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against infectious viruses</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The COVID&#x2d;19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID&#x2d;19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID&#x2d;19 in the first year alone.</p>
<p><a href="https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/10/19140258/banner-image-DoriVac.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=02c46a8a5e23e0c41c361cb65f4eb81c"/></url>
				</image>
        			</item>

		
			<item>
				<title>Namita Sarraf on Using DNA as a Building Block</title>
				<link>https://wyss.harvard.edu/news/namita-sarraf-on-using-dna-as-a-building-block/</link>
        <pubDate>Thu, 18 Sep 2025 15:26:34 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43699</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Namita Sarraf loves to find herself at intersections, whether it&rsquo;s pursuing a Ph.D. at the nexus of bioengineering and computer science or hosting a &ldquo;Diwali&#x2d;sgiving&rdquo; dinner party to&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/namita-sarraf-on-using-dna-as-a-building-block/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/namita-sarraf-on-using-dna-as-a-building-block/</link>
          <title>Namita Sarraf, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/09/16161112/HoW-Namita-Sarraf-09258-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7557ae3692ee9bddf1d31db319fc54c7"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2025-2026 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
        <pubDate>Thu, 14 Aug 2025 15:00:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43463</guid>
                            <description>14 teams supported this year to advance projects with future potential for real-world impact through the Wyss’ technology innovation funnel</description>
                                        <content:encoded><![CDATA[<p>Throughout recent years, the Wyss&rsquo; Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick&#x2d;starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi&#x2d;talented teams&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
          <title>Senior Scientist Kwasi Adu-Berchie (center) is leading the TIB project team with Core Faculty member David Mooney (left). The team is developing tolerance-inducing biomaterials to offer patients safer, longer-lasting treatments for conditions ranging from autoimmune disease to tissue and bone injury. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/08/13101608/Dave-Mooney-Lab-Candid-Lab-Coat-07873-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b0631ddd4c73659862b34b403e537e4f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Anastasia Ershova on Designing and Building with RNA and DNA</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-anastasia-ershova-on-designing-and-building-with-rna-and-dna/</link>
        <pubDate>Tue, 29 Jul 2025 13:52:34 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43257</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Anastasia Ershova loves fencing because every opponent is a new puzzle to solve, and both fencers are constantly engaged, making adjustments based on each other&rsquo;s actions. The same could be&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-anastasia-ershova-on-designing-and-building-with-rna-and-dna/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-anastasia-ershova-on-designing-and-building-with-rna-and-dna/</link>
          <title>Anastasia Ershova, Scientist II. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/07/28084250/HoW-Anastasia-Ershova-08737-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5d4acda20ce8057ba3338c0fa41aa127"/></url>
				</image>
        			</item>

		
			<item>
				<title>DNA Nanoswitch Calipers for Single-Molecule Proteomics</title>
				<link>https://wyss.harvard.edu/technology/dna-nanoswitch-calipers-for-single-molecule-proteomics/</link>
        <pubDate>Tue, 15 Oct 2024 16:48:31 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA Nanoswitches]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Nanoswitch]]></category>
		<category><![CDATA[Origami]]></category>
		<category><![CDATA[Wesley Wong]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=41172</guid>
                                                <content:encoded><![CDATA[<p>Proteins are well known as essential orchestrators of life, but what is less well&#x2d;understood is their post&#x2d;translational modifications (PTMs). These modifications can include the attachment of chemical groups, carbohydrates, or lipids to the proteins, which affect their folding, stability, and functions. Certain protein PTMs have been linked to diabetes, cancer, and neurodegenerative disease&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/dna-nanoswitch-calipers-for-single-molecule-proteomics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/dna-nanoswitch-calipers-for-single-molecule-proteomics/</link>
          <title>Credit: Envato/vladimirzotov</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2024/10/10123749/3d-illustration-atom-connection-concept-abstrack-2024-09-23-03-15-30-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1abaaa80210f4700f2608887d488ceea"/></url>
				</image>
        			</item>

		
			<item>
				<title>DoriNano &#8211; Improved DNA Origami Nanodelivery to Fight Cancer and Other Diseases</title>
				<link>https://wyss.harvard.edu/media-post/dorinano-improved-dna-origami-nanodelivery-to-fight-cancer-and-other-diseases/</link>
        <pubDate>Fri, 04 Oct 2024 18:20:45 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Cancer Vaccine]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41135</guid>
                                                <content:encoded><![CDATA[<p>We&rsquo;re developing DNA Origami nanodelivery, which is transforming nanoparticle industry. Developed at the Dana Farber Cancer Institute and the Wyss Institute at Harvard University, this innovative approach overcomes the challenges of other nanoparticles, offering stability, high drug loading capacity, nano&#x2d;scale control of cargo spacing, and more &ndash; making it a highly customizable solution for&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/dorinano-improved-dna-origami-nanodelivery-to-fight-cancer-and-other-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/dorinano-improved-dna-origami-nanodelivery-to-fight-cancer-and-other-diseases/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2024/10/04142026/THUMBNAIL-DoriNano-Improved-DNA-Origami-Nanodelivery-to-Fight-Cancer-and-Other-Diseases_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=25e304207f7e689f8c5435252ec1975b"/></url>
				</image>
        			</item>

			</channel>
</rss>
